EUROPE VETERINARY VACCINES MARKET 2019-2028

Lifesciences | Healthcare & Wellness

EUROPE VETERINARY VACCINES MARKET 2019-2028

Market by Vaccine Type, Technology, Disease Type, and Country | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton's research report, Europe veterinary vaccines market is projected to gather a CAGR of 5.57% based on revenue during the years of 2019-2028.

Report scope can be customized per your requirements. Request For Customization

The countries examined in this market comprise:

•        The UK

•        Spain

•        Germany

•        Italy

•        France

•        Russia

•        Rest of Europe

The rising animal diseases and strict government regulations to sustain livestock are factors stimulating the growth of the European veterinary vaccines market. The European pharmacopeia entails various rules relating to the suitable dosage of vaccines. Moreover, it states that each batch of vaccines has to be tested for efficiency to prove their appropriate potency. These regulations guarantee adequate supervision over veterinary vaccines, which increases their utilization to prevent diseases. This further fuels the veterinary vaccines market in the region.  

In the United Kingdom, the vaccines developed to curb zoonotic diseases in food and companion animals have assisted in reducing the prevalence of zoonotic diseases in the country. The increasing demand for food production, paired with a surge in animal health awareness, is expected to stimulate the progress of veterinary vaccines during the projected phase. Furthermore, the Veterinary Vaccinology Network’s (VVN) efforts to develop new technologies to meet the needs of veterinary vaccinology are creating awareness about these vaccines in the country. Additionally, the licensed vaccines are required to meet strict regulatory guidelines, which includes providing their production and supplier information. Hence, the initiatives to promote animal vaccines, along with stringent regulations, are generating numerous growth opportunities for the studied market in the UK.

Boehringer Ingelheim Animal Health GmbH is one of the leading pharmaceutical companies which develops, produces, markets, and sells pharmaceutical products. The company provides animal health products, such as biologicals and natural care products for cattle, swine, horses, and companion animals. The firm functions in five segments, namely, prescription medicines, animal health, biopharmaceuticals, industrial customer, and others. Its operations are spread across various countries, with its headquarters located in Germany.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    EUROPE VETERINARY VACCINES MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   THREAT OF COMPETITIVE RIVALRY

2.3. IMPACT OF COVID-19 ON VETERINARY VACCINES MARKET

2.4. INDUSTRY COMPONENTS

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. MARKET DRIVERS

2.7.1.   GROWTH IN PREVALENCE OF ZOONOTIC DISEASES

2.7.2.   RISE IN LIVESTOCK DISEASES

2.8. MARKET RESTRAINTS

2.8.1.   ADVERSE EFFECTS OF POST-VACCINATION

2.8.2.   SHORTAGE OF SKILLED FARMWORKERS

2.9. MARKET OPPORTUNITIES

2.9.1.   INCREASE IN NUMBER OF INITIATIVES BY GOVERNMENT AGENCIES

2.9.2.   GROWTH IN MOMENTUM OF PET OWNERSHIP

2.10.  MARKET CHALLENGE

2.10.1.  HIGH COSTS OF VACCINATIONS

3.    EUROPE VETERINARY VACCINES MARKET OUTLOOK - BY VACCINE TYPE

3.1. LIVESTOCK VACCINE

3.1.1.   PORCINE VACCINE

3.1.2.   BOVINE VACCINE

3.1.3.   POULTRY VACCINE

3.1.4.   AQUACULTURE VACCINE

3.1.5.   OTHER LIVESTOCK VACCINE

3.2. COMPANION VACCINE

3.2.1.   CANINE VACCINE

3.2.2.   FELINE VACCINE

3.2.3.   EQUINE VACCINE

4.    EUROPE VETERINARY VACCINES MARKET OUTLOOK - BY TECHNOLOGY

4.1. LIVE ATTENUATED VACCINE

4.2. INACTIVATED VACCINE

4.3. RECOMBINANT VACCINE

4.4. TOXOID VACCINE

4.5. OTHER TECHNOLOGY

5.    EUROPE VETERINARY VACCINES MARKET OUTLOOK - BY DISEASE TYPE

5.1. CANINE DISEASE

5.2. PORCINE DISEASE

5.3. BOVINE DISEASE

5.4. POULTRY DISEASE

5.5. AQUACULTURE DISEASE

5.6. OTHER DISEASE TYPE

6.    EUROPE VETERINARY VACCINES MARKET – REGIONAL OUTLOOK

6.1. COUNTRY ANALYSIS

6.1.1.   THE UNITED KINGDOM

6.1.2.   FRANCE

6.1.3.   GERMANY

6.1.4.   ITALY

6.1.5.   RUSSIA

6.1.6.   SPAIN

6.1.7.   REST OF EUROPE

7.    COMPANY PROFILES

7.1. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH

7.2. CEVA SANTE ANIMALE

7.3. HYGIEIA BIOLOGICAL LABORATORIES

7.4. ANICON LABOR GMBH

7.5. PHIBRO ANIMAL HEALTH CORP

7.6. ROMVAC COMPANY SA

7.7. ELANCO (ELI LILLY AND COMPANY)

7.8. VAXXINOVA GMBH-GERMANY

7.9. ZOETIS

7.10.   HESTER BIOSCIENCES LIMITED

7.11.   HIPRA

7.12.  VIRBAC SA

7.13. MERCK & CO

7.14. NEOGEN CORPORATION

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1: EUROPE VETERINARY VACCINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

TABLE 2: MARKET SNAPSHOT - VETERINARY VACCINE

TABLE 3: VENDOR SCORECARD

TABLE 4: EUROPE VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)

TABLE 5: EUROPE LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 6: COMMERCIALLY AVAILABLE PORCINE VACCINES

TABLE 7: COMMERCIALLY EUROPE AVAILABLE POULTRY VACCINES

TABLE 8: EUROPE COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 9: COMMERCIALLY AVAILABLE CANINE VACCINES

TABLE 10: COMMERCIALLY AVAILABLE FELINE VACCINES

TABLE 11: COMMERCIALLY AVAILABLE EQUINE VACCINES

TABLE 12: EUROPE VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)

TABLE 13: EUROPE VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)

List of Figures

FIGURE 1: EUROPE VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 2: EUROPE VETERINARY VACCINES MARKET, BY LIVESTOCK VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 3: EUROPE LIVESTOCK VACCINE MARKET, BY PORCINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 4: EUROPE LIVESTOCK VACCINE MARKET, BY BOVINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 5: EUROPE LIVESTOCK VACCINE MARKET, BY POULTRY VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 6: EUROPE LIVESTOCK VACCINE MARKET, BY AQUACULTURE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 7: EUROPE LIVESTOCK VACCINE MARKET, BY OTHER LIVESTOCK VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 8: EUROPE VETERINARY VACCINES MARKET, BY COMPANION VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 9: EUROPE COMPANION VACCINE MARKET, BY CANINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 10: EUROPE COMPANION VACCINE MARKET, BY FELINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 11: EUROPE COMPANION VACCINE MARKET, BY EQUINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 12: EUROPE VETERINARY VACCINES MARKET, BY LIVE ATTENUATED VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 13: EUROPE VETERINARY VACCINES MARKET, BY INACTIVATED VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 14: EUROPE VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 15: EUROPE VETERINARY VACCINES MARKET, BY TOXOID VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 16: EUROPE VETERINARY VACCINES MARKET, BY OTHER TECHNOLOGY, 2019-2028 (IN $ MILLION)

FIGURE 17: EUROPE VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 18: EUROPE VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 19: EUROPE VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 20: EUROPE VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 21: EUROPE VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 22: EUROPE VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2019-2028 (IN $ MILLION)

FIGURE 23: THE UNITED KINGDOM VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 24: FRANCE VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 25: GERMANY VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 26: ITALY VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 27: RUSSIA VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 28: SPAIN VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 29: REST OF EUROPE VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)            

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;